Advertisement
Review article| Volume 22, P97-102, May 2018

Download started.

Ok

Evolution of multiple sclerosis prevalence and phenotype in Latin America

      Highlights

      • Latin America is a low-medium MS prevalence region.
      • Local genetic and environmental factors contribute to the lower prevalence of MS.
      • Prevalence and incidence of MS are increasing in Latin America.
      • MS phenotype is similar in Latin American patients compared to Caucasian patients.
      • Female-to-male ratio is increasing in Latin American MS patients.

      Abstract

      Background

      Literature regarding MS epidemiology and phenotype is scarce but has increased markedly over the past years. The objective of the present work is to assess the evolution of the prevalence and phenotype of MS in Latin America during recent years.

      Methods

      Review of literature.

      Results

      MS prevalence levels are low to medium in Latin America, although these have increased in recent years. A small latitudinal gradient has also been observed, but exceptions to this rule exist, suggesting other genetic and environmental factors ultimately influence regional prevalence rates. One of the distinctive features of the region is the complex genetic admixture arising from multiple divergent population ancestries in different countries including: Native Americans, Caucasians and Africans. Another variable which would lower MS risk in the region could be a protective effect linked to exposure to certain infections, such as parasites. Despite differences in MS epidemiology, Latin American patients show an MS phenotype very similar to that of Caucasian patients, and a progressively increasing female gender ratio as has been described worldwide.

      Conclusion

      MS epidemiology in Latin American patients has distinctive features. Both, prevalence and incidence, are increasing.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Multiple Sclerosis and Related Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Amezcua L.
        • Oksenberg J.R.
        • McCauley J.L.
        MS in self-identified Hispanic/Latino individuals living in the US.
        Mult. Scler. J. – Exp. Transl. Clin. [Internet]. 2017; 3https://doi.org/10.1177/2055217317725103
        • Ascherio A.
        • Munger K.L.
        Environmental risk factors for multiple sclerosis. Part I: the role of infection.
        Ann. Neurol. 2007; 61: 288-299
        • Aurenção J.C.K.
        • Vasconcelos C.C.F.
        • Thuler L.C.S.
        • Alvarenga R.M.P.
        Disability and progression in Afro-descendant patients with multiple sclerosis.
        Arq. Neuropsiquiatr. [Internet]. 2016; 74 (Available from): 836-841
        • Avena S.
        • Via M.
        • Ziv E.
        • Pérez-Stable E.J.
        • Gignoux C.R.
        • Dejean C.
        • et al.
        Heterogeneity in genetic admixture across different regions of argentina.
        PLoS One. 2012; 7: 4
        • Burkill S.
        • Montgomery S.
        • Hajiebrahimi M.H.
        • Hillert J.
        • Olsson T.
        • Bahmanyar S.
        Mortality trends for multiple sclerosis patients in Sweden from 1968 to 2012.
        Neurology. 2017; 89: 555-562
        • Cabre P.
        • Signate A.
        • Olindo S.
        • Merle H.
        • Caparros-Lefebvre D.
        • Béra O.
        • et al.
        Role of return migration in the emergence of multiple sclerosis in the French West Indies.
        Brain. 2005; 128: 2899-2910
        • Callegaro D.
        • Goldbaum M.
        • Morais L.
        • Tilbery C.P.
        • Moreira M.A.
        • Gabbai A.A.
        • et al.
        The prevalence of multiple sclerosis in the city of São Paulo, Brazil, 1997.
        Acta Neurol. Scand. 2001; 104: 208-213
        • Calmon A.B.
        • Pereira F.
        • Marin B.
        • Preux P.M.
        • Alvarenga R.P.
        Prevalence of multiple sclerosis in the City of Volta Redonda - Rio De Janeiro, Brazil using the capture-recapture method.
        Neuroepidemiology. 2016; 46: 88-95
        • Calmon Nogueira Da Gama Pereira A.B.
        • Clinete Sampaio Lacativa M.
        • Ferreira Chaves Da Costa Pereira F.
        • Papais Alvarenga R.M.
        Prevalence of multiple sclerosis in Brazil: a systematic review.
        Mult. Scler. Relat. Disord. [Internet]. 2015; 4: 572-579https://doi.org/10.1016/j.msard.2015.08.004
        • Chinea A.
        • Ríos-Bedoya C.F.
        • Rubi C.
        • Vicente I.
        • Estades E.R.
        • Hernandez-Silvestrini Y.G.
        Incidence of multiple sclerosis in Puerto Rico, 2014: a population-based study.
        Neuroepidemiology. 2017; 48: 55-60
        • Correa E.
        • Paredes V.
        • Martínez B.
        Prevalence of multiple sclerosis in Latin America and its relationship with European migration.
        Mult. Scler. J. – Exp. Transl. Clin. [Internet]. 2016; 2https://doi.org/10.1177/2055217316666407
        • Correale J.
        • Farez M.
        ssociation between parasite infection and immune responses in multiple sclerosis.
        Ann. Neurol. [Internet]. 2017; 61: 97-108
        • Correale J.
        • Farez M.F.
        Modulation of multiple sclerosis by sunlight exposure: Role of cis-urocanic acid.
        J Neuroimmunol [Internet]. 2017; 26: 134-140
        • Correale J.
        • Ysrraelit M.C.
        • Gaitán M.I.
        Immunomodulatory effects of Vitamin D in multiple sclerosis.
        Brain. 2009; 132: 1146-1160
        • Correale J.
        • Farez M.F.
        • Gaitán M.I.
        Environmental factors influencing multiple sclerosis in Latin America.
        Mult. Scler. J. – Exp. Transl. Clin. [Internet]. 2017; 3 (205521731771504)
        • Cristiano E.
        • Patrucco L.
        • Miguez J.
        • Giunta D.
        • Correale J.
        • Fiol M.
        • et al.
        Increasing prevalence of multiple sclerosis in Buenos Aires, Argentina.
        Mult. Scler. Relat. Disord. [Internet]. 2016; 9: 91-94https://doi.org/10.1016/j.msard.2016.07.007
        • Cristiano E.
        • Patrucco L.
        • Miguez J.
        • Giunta D.
        • Peroni J.
        • Rojas J.I.
        Increasing incidence of multiple sclerosis among women in Buenos Aires: a 22 year health maintenance organization based study.
        Neurol. Sci. 2016; 37: 1621-1626
        • Díaz V.
        • Barahona J.
        • Antinao J.
        • Quezada R.
        • Delgado I.
        • Silva C.
        • et al.
        Incidence of multiple sclerosis in Chile. A hospital registry study.
        Acta Neurol. Scand. 2012; 125: 71-75
        • Escobar V.D.
        • Escobar Darwin V.
        • Castillo Jorge K.
        • Barba Carlos C.
        • Gutierrez Ana C.
        • Barbarán Martin T.
        • et al.
        Prevalencia de Esclerosis Múltiple en Lima – Perú. Prevalence of multiple sclerosis in Lima -Perú.
        146 Rev. Med. Hered. 2009; 20: 146-150
        • Farez M.F.
        • Balbuena Aguirre M.E.
        • Varela F.
        • Köhler A.A.
        • Nagel V.
        • Correale J.
        Low familial risks for multiple sclerosis in Buenos Aires, Argentina.
        J. Neurol. Sci. [Internet]. 2014; 346: 268-270https://doi.org/10.1016/j.jns.2014.09.004
        • Farez M.F.
        • Mascanfroni I.D.
        • Méndez-Huergo S.P.
        • Yeste A.
        • Murugaiyan G.
        • Garo L.P.
        • et al.
        Melatonin contributes to the seasonality of multiple sclerosis relapses.
        Cell. 2015; 162: 1338-1352
        • Fleming J.O.
        • Cook T.D.
        Multiple sclerosis and the hygiene hypothesis.
        Neurology. 2006; 67: 2085-2086
        • Flores J.
        • González S.
        • Morales X.
        • Yescas P.
        • Ochoa A.
        • Corona T.
        Absence of Multiple sclerosis and demyelinating diseases among lacandonians, a pure amerindian ethnic group in Mexico.
        Mult. Scler. Int. [Internet]. 2012; 2012 (Available from): 1-4
        • Flores J.
        • Granados J.
        • Alonso E.
        • Rito Y.
        • Ortega-Hernández E.
        • Mena-Hernández L.
        • et al.
        Presence of the HLADR13 allele among Mexican Mestizos suggests a protective factor against relapsing-remitting multiple sclerosis (RRMS).
        Clin. Neurol. Neurosurg. [Internet]. 2015; 138: 184-187https://doi.org/10.1016/j.clineuro.2015.08.016
        • Gonzalez O.
        • Sotelo J.
        Is the frequency of multiple sclerosis increasing in Mexico?.
        J. Neurol. Neurosurg. Psychiatry. 1995; 59: 528-530
        • Gracia F.
        • Castillo L.C.
        • Benzadón A.
        • Larreategui M.
        • Villareal F.
        • Triana E.
        Prevalence and Incidence of Multiple Sclerosis in Panama (2000–2005).
        Neuroepidemiol. [Internet]. 2009; 32: 287-293
        • Jiménez-Pérez C.E.
        • Zarco-Montero L.A.
        • Castañeda-Cardona C.
        • Otálora Esteban M.
        • Martínez A.
        • Rosselli D.
        Estado actual de la esclerosis múltiple en Colombia.
        Acta Neurol. Colomb. 2015; 31: 385-390
        • Koch-Henriksen N.
        • Sørensen P.S.
        The changing demographic pattern of multiple sclerosis epidemiology.
        Lancet Neurol. [Internet]. 2017; 9: 520-532
        • McDonald W.I.
        • Compston A.
        • Edan G.
        • Goodkin D.
        • Hartung H.P.
        • Lublin F.D.
        • et al.
        Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.
        Ann. Neurol. [Internet]. 2018; 50: 121-127
        • Melcon M.
        • Gold L.
        • Carrá A.
        • Cáceres F.
        • Correale J.
        • Cristiano E.
        • et al.
        Argentine Patagonia: prevalence and clinical features of multiple sclerosis.
        Mult. Scler. J. [Internet]. 2008; 14https://doi.org/10.1177/1352458507085801
        • Melcon M.
        • Melcon C.
        • Bartoloni L.
        • Cristiano E.
        • Duran J.
        • Grzesiuk A.
        • et al.
        Towards establishing MS prevalence in Latin America and the Caribbean.
        Mult. Scler. J. [Internet]. 2013; 19: 145-152https://doi.org/10.1177/1352458512441985
        • Melcon M.O.
        • Correale J.
        • Melcon C.M.
        Is it time for a new global classification of multiple sclerosis?.
        J. Neurol. Sci. 2014; 344: 171-181
        • Mirsattari S.M.
        • Johnston J.B.
        • McKenna R.
        • del Bigio M.R.
        • Orr P.
        • Ross R.T.
        • et al.
        Aboriginals with multiple sclerosis: HLA types and predominance of neuromyelitis optica.
        Neurol. [Internet]. 2001; 56 (Available from: papers3://publication/uuid/AE85AA06-4D50-4227-8E3E-29C4E160191B): 317-323
        • Oehninger C.
        • Ketzoian C.
        • Buzó R.
        • Rega I.
        • Gómez A.
        • García M.
        • et al.
        ECTRIMS 98. 14th Congress of the European Committee for Treatment and Research in Multiple Sclerosis. Stockholm, Sweden, 9-12 September 1998. Abstracts.
        Mult. Scler. [Internet]. 1998; 4: 372
        • Papais-Alvarenga R.M.
        • Vasconcelos C.C.F.
        • Carra A.
        • De Castillo I.S.
        • Florentin S.
        • De Bedoya F.H.D.
        • et al.
        Central nervous system idiopathic inflammatory demyelinating disorders in South Americans: a descriptive, multicenter, cross-sectional study.
        PLoS One. 2015; 10: 1-20
        • Papais-Alvarenga R.M.
        • Pereira F.F.C.C.
        • Bernardes M.S.
        • Papais-Alvarenga M.
        • Batista E.
        • Paiva C.A.
        • et al.
        Familial forms of multiple sclerosis and neuromyelitis optica at an MS center in Rio de Janeiro state, Brazil.
        J. Neurol. Sci. [Internet]. 2015; 356: 196-201https://doi.org/10.1016/j.jns.2015.06.034
        • Patrucco L.
        • Rojas J.
        • Miguez J.
        • Cristiano E.
        Application of the McDonald 2010 criteria for the diagnosis of multiple sclerosis in an Argentinean cohort of patients with clinically isolated syndromes.
        Mult. Scler. J. [Internet]. 2013; 19: 1297-1301https://doi.org/10.1177/1352458513475492
        • Polman C.H.
        • Reingold S.C.
        • Banwell B.
        • Clanet M.
        • Cohen J.A.
        • Filippi M.
        • et al.
        Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria.
        Ann. Neurol. 2011; 69: 292-302
      1. Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.-.P., Kappos L.. et al. 2018. Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald Criteria. Ann Neurol [Internet]. 2005 Dec [cited Feb 15];58(6):840–6. Available from: 〈http://www.ncbi.nlm.nih.gov/pubmed/16283615〉.

      2. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C.. et al. 2018. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol [Internet]. 1983 Mar [cited Feb 15];13(3):227–231. Available from: 〈http://www.ncbi.nlm.nih.gov/pubmed/6847134〉.

        • Ramagopalan S.V.
        • Morris A.P.
        • Dyment D.A.
        • Herrera B.M.
        • DeLuca G.C.
        • Lincoln M.R.
        • et al.
        The inheritance of resistance alleles in multiple sclerosis.
        PLoS Genet. 2007; 3: 1607-1613
        • Ribbons K.
        • Lea R.
        • Tiedeman C.
        • Mackenzie L.
        • Lechner-Scott J.
        Ongoing increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 50-year study.
        Mult. Scler. 2017; 23: 1063-1071
        • Risco J.
        • Maldonado H.
        • Luna L.
        • Osada J.
        • Ruiz P.
        • Juarez A.
        • et al.
        Latitudinal prevalence gradient of multiple sclerosis in Latin America.
        Mult. Scler. J. [Internet]. 2011; 17: 1055-1059https://doi.org/10.1177/1352458511405562
        • Rivera V.M.
        Multiple sclerosis: changing trends in Latin Americans. Epidemiology and regional characteristics. August 2017.
        Int. Med. Rev. 2017; 3: 1-9
        • Rivera V.M.
        Multiple sclerosis in Latin Americans: genetic aspects.
        Curr. Neurol. Neurosci. Rep. 2017; 17: 8
        • Rojas J.I.
        • Patrucco L.
        • Miguez J.
        • Sinay V.
        • Cassara F.P.
        • Cáceres F.
        • et al.
        Disease onset in familial and sporadic multiple sclerosis in Argentina.
        Mult. Scler. Relat. Disord. [Internet]. 2016; 6: 54-56https://doi.org/10.1016/j.msard.2016.01.004
        • Rojas J.I.
        • Patrucco L.
        • MIguez J.
        • Sinay V.
        • Cassara F.P.
        • Cáceres F.
        • et al.
        Gender ratio trends over time in multiple sclerosis patients from Argentina.
        J. Clin. Neurosci. [Internet]. 2017; 38: 84-86https://doi.org/10.1016/j.jocn.2016.12.030
        • Tao C.
        • Simpson S.
        • van der Mei I.
        • Blizzard L.
        • Havrdova E.
        • Horakova D.
        • et al.
        Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis.
        J. Neurol. Neurosurg. Psychiatry [Internet]. 2016; 87https://doi.org/10.1136/jnnp-2016-314013
        • Taylor B.V.
        • Pearson J.F.
        • Clarke G.
        • Mason D.F.
        • Abernethy D.A.
        • Willoughby E.
        • et al.
        MS prevalence in New Zealand, an ethnically and latitudinally diverse country.
        Mult. Scler. 2010; 16: 1422-1431
        • Thompson A.J.
        • Banwell B.L.
        • Barkhof F.
        • Carroll W.M.
        • Coetzee T.
        • Comi G.
        • et al.
        Diagnosis of multiple sclerosis: 2017 Revisions of the McDonald criteria.
        Lancet Neurol. 2017; 17
      3. Tokunaga K., Ohashi J., Bannai M., Juji T., 2018. Genetic link between Asians and native Americans: evidence from HLA genes and haplotypes. Hum Immunol [Internet]. 2001 Sep 1 [cited Feb 13];62(9):1001–1008. Available from: 〈https://www.sciencedirect.com/science/article/pii/S0198885901003019?Via%3Dihub〉.

        • Toro J.
        • Cárdenas S.
        • Fernando Martínez C.
        • Urrutia J.
        • Díaz C.
        Multiple sclerosis in Colombia and other Latin American Countries.
        Mult. Scler. Relat. Disord. 2013; 2: 80-89
        • Toro J.
        • Cuellar-Giraldo D.
        • Díaz-Cruz C.
        • Burbano L.E.
        • Guío C.M.
        • Reyes S.
        • et al.
        HLA-DRB1∗14 is a protective allele for multiple sclerosis in an admixed colombian population.
        Neurol. Neuroimmunol. Neuroinflamm. 2016; 3: 1-5
        • Trojano M.
        • Lucchese G.
        • Graziano G.
        • Taylor B.V.
        • Simpson S.
        • Lepore V.
        • et al.
        Geographical variations in sex ratio trends over time in multiple sclerosis.
        PLoS One. 2012; 7: 10
        • Velázquez-Quintana M.
        • Macías-Islas M.A.
        • Rivera-Olmos V.
        • Lozano-zárate J.
        Esclerosis múltiple en México: un estudio multicéntrico.
        Rev. Neurol. 2003; 36: 1019-1022
        • Ventura R.E.
        • Antezana A.O.
        • Bacon T.
        • Kister I.
        Hispanic Americans and African Americans with multiple sclerosis have more severe disease course than Caucasian Americans.
        Mult. Scler. J. [Internet]. 2017; 23: 1554-1557https://doi.org/10.1177/1352458516679894